Abstract
OBJECTIVES: To determine the risk of perinatal transmission of hepatitis B virus (HBV) in Jordan. METHODS: Plasma samples from 1000 pregnant Jordanian women were screened by ELISA for HBV markers (HBsAg, HBeAg, anti-HBe, anti-HBc and anti-HBs). RESULTS: HBsAg and HBeAg were detected in 4.3% and 0.1% of the pregnant women, respectively. The overall prevalence of antibodies was 6%, 11.1% and 7.5% for anti-HBe, anti-HBc and anti-HBs, respectively. Women were assigned to four groups according to the serological patterns of HBV markers: susceptible (85.9%), with acute infection (2.9%), with chronic infection (1.4%) and previously infected (9.8%). Most women were at the third trimester of pregnancy, therefore women with acute and chronic hepatitis at this gestational age were at risk of transmitting HBV infection to their newborns. Women who belonged to the low socio-economic class were at higher risk of HBV infection. CONCLUSIONS: Based on the results, we recommend screening women for HBV during pregnancy in order to identify HBV carriers. All newborns born to carriers should be vaccinated immediately after birth, both passively and actively. Also vaccination of HBV seronegative pregnant women is recommended.
Full Text
The Full Text of this article is available as a PDF (99.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- André F. E., Zuckerman A. J. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol. 1994 Oct;44(2):144–151. doi: 10.1002/jmv.1890440206. [DOI] [PubMed] [Google Scholar]
- Bahn A., Hilbert K., Martiné U., Westedt J., von Weizsäcker F., Wirth S. Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants. J Med Virol. 1995 Dec;47(4):336–341. doi: 10.1002/jmv.1890470408. [DOI] [PubMed] [Google Scholar]
- Balistreri W. F. Viral hepatitis. Pediatr Clin North Am. 1988 Apr;35(2):375–407. doi: 10.1016/s0031-3955(16)36436-7. [DOI] [PubMed] [Google Scholar]
- Bart P. A., Jacquier P., Zuber P. L., Lavanchy D., Frei P. C. Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery. Liver. 1996 Apr;16(2):110–116. doi: 10.1111/j.1600-0676.1996.tb00714.x. [DOI] [PubMed] [Google Scholar]
- Beasley R. P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988 May 15;61(10):1942–1956. doi: 10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- Beasley R. P., Hwang L. Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983 Feb;147(2):185–190. doi: 10.1093/infdis/147.2.185. [DOI] [PubMed] [Google Scholar]
- Duff P. Hepatitis in pregnancy. Semin Perinatol. 1998 Aug;22(4):277–283. doi: 10.1016/s0146-0005(98)80016-5. [DOI] [PubMed] [Google Scholar]
- Guidozzi F., Schoub B. D., Johnson S., Song E. Should pregnant urban south African women be screened for hepatitis B? S Afr Med J. 1993 Feb;83(2):103–105. [PubMed] [Google Scholar]
- Kuru U., Turan O., Kuru N., Saglam Z., Ceylan Y., Nurluoglu M., Agacfidan A. Prevalence of hepatitis B virus infection in pregnant Turkish women and their families. Eur J Clin Microbiol Infect Dis. 1996 Mar;15(3):248–251. doi: 10.1007/BF01591364. [DOI] [PubMed] [Google Scholar]
- Lazizi Y., Badur S., Perk Y., Ilter O., Pillot J. Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine. 1997 Jul;15(10):1095–1100. doi: 10.1016/s0264-410x(97)00005-4. [DOI] [PubMed] [Google Scholar]
- Lin H. H., Hsu H. Y., Lee T. Y., Hsieh R. P., Chen P. J., Chen D. S. Age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. Asia Oceania J Obstet Gynaecol. 1994 Jun;20(2):141–145. doi: 10.1111/j.1447-0756.1994.tb00440.x. [DOI] [PubMed] [Google Scholar]
- Ngui S. L., Andrews N. J., Underhill G. S., Heptonstall J., Teo C. G. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis. 1998 Jul;27(1):100–106. doi: 10.1086/514610. [DOI] [PubMed] [Google Scholar]
- Poovorawan Y., Sanpavat S., Pongpunlert W., Chumdermpadetsuk S., Sentrakul P., Safary A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA. 1989 Jun 9;261(22):3278–3281. [PubMed] [Google Scholar]
- Pujol F. H., Rodríguez I., Martínez N., Borberg C., Favorov M. O., Fields H. A., Liprandi F. Viral hepatitis serological markers among pregnant women in Caracas, Venezuela: implication for perinatal transmission of hepatitis B and C. G E N. 1994 Jan-Mar;48(1):25–28. [PubMed] [Google Scholar]